Comments
Loading...

Rocket Pharmaceuticals

RCKTNASDAQ
Logo brought to you by Benzinga Data
$20.84
-0.96-4.40%
At Close: -
$20.90
0.060.29%
After Hours: 7:06 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$75.00
Lowest Price Target1
$22.00
Consensus Price Target1
$48.44

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock, Analyst Ratings, Price Targets, Forecasts

Rocket Pharmaceuticals Inc has a consensus price target of $48.44 based on the ratings of 16 analysts. The high is $75 issued by Evercore ISI Group on September 30, 2022. The low is $22 issued by Raymond James on July 8, 2022. The 3 most-recent analyst ratings were released by Needham, JP Morgan, and Cantor Fitzgerald on September 17, 2024, August 6, 2024, and August 6, 2024, respectively. With an average price target of $57 between Needham, JP Morgan, and Cantor Fitzgerald, there's an implied 172.73% upside for Rocket Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Jun
0
0
0
0
Jul
2
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
JP Morgan
Cantor Fitzgerald
Chardan Capital
Canaccord Genuity

1calculated from analyst ratings

Analyst Ratings for Rocket Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Rocket Pharmaceuticals (RCKT) stock?

A

The latest price target for Rocket Pharmaceuticals (NASDAQ:RCKT) was reported by Needham on September 17, 2024. The analyst firm set a price target for $52.00 expecting RCKT to rise to within 12 months (a possible 148.80% upside). 18 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Rocket Pharmaceuticals (RCKT)?

A

The latest analyst rating for Rocket Pharmaceuticals (NASDAQ:RCKT) was provided by Needham, and Rocket Pharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for Rocket Pharmaceuticals (RCKT)?

A

There is no last upgrade for Rocket Pharmaceuticals

Q

When was the last downgrade for Rocket Pharmaceuticals (RCKT)?

A

There is no last downgrade for Rocket Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Rocket Pharmaceuticals (RCKT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rocket Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rocket Pharmaceuticals was filed on September 17, 2024 so you should expect the next rating to be made available sometime around September 17, 2025.

Q

Is the Analyst Rating Rocket Pharmaceuticals (RCKT) correct?

A

While ratings are subjective and will change, the latest Rocket Pharmaceuticals (RCKT) rating was a reiterated with a price target of $52.00 to $52.00. The current price Rocket Pharmaceuticals (RCKT) is trading at is $20.90, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch